27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Inovio Pharmaceuticals (NASDAQ:INO) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings
Inovio Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.
Revenue was down $84 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 4.84% increase in the share price the next day.
Here's a look at Inovio Pharmaceuticals's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.30 | -0.31 | -0.34 |
| EPS Actual | -0.22 | -0.15 | -0.46 | -0.36 |
| Revenue Estimate | 340K | 620K | 520K | 670K |
| Revenue Actual | 125K | 9.15M | 784K | 199K |
To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.